Background: Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. Recently circRNAs were proved associated with malignant hematopoietic differentiation process. However, evidence regarding single-nucleotide polymorphisms (SNP) of circRNA biogenesis key regulator genes and the risk of ALL is still fairly elusive. Methods: To evaluate the novel circRNA biogenesis associated genes SNPs susceptible to ALL, we carried out a case-control study genotyping 6 SNPs in 782 cases of ALL and 1077 controls. Following that, stratified analysis and prognosis analysis were performed. In addition, we detected the gene expression levels of the ALL associated genetic variants. Results: After adjustment for multiple testing, we found two genetic variants, QKI (rs715020 A > G) and ILF3 (rs3810156 C > G), exhibited a significant association with increased susceptibility to ALL. The associations were further validated by stratified analyses. Moreover, rs715020 A > G indeed affected the expression level of QKI, which showed higher mRNA levels. Of note, the polymorphisms QKI rs715020 was identified as a predictor of chemotherapy outcome.Conclusions: Our results suggested that circRNA biogenesis-related genes were associated with the ALL risk and highlight plausible interplay between genetic variants in ALL treatment.